KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Net Income (2016 - 2025)

Historic Net Income for Biolife Solutions (BLFS) over the last 15 years, with Q4 2024 value amounting to $14.6 million.

  • Biolife Solutions' Net Income rose 15504.46% to $14.6 million in Q4 2024 from the same period last year, while for Sep 2025 it was $14.6 million, marking a year-over-year increase of 12925.19%. This contributed to the annual value of -$8.8 million for FY2024, which is 8224.8% up from last year.
  • Per Biolife Solutions' latest filing, its Net Income stood at $14.6 million for Q4 2024, which was up 15504.46% from -$1.2 million recorded in Q3 2024.
  • In the past 5 years, Biolife Solutions' Net Income ranged from a high of $91.0 million in Q4 2022 and a low of -$72.9 million during Q2 2022
  • Over the past 5 years, Biolife Solutions' median Net Income value was -$5.9 million (recorded in 2023), while the average stood at -$3.7 million.
  • Data for Biolife Solutions' Net Income shows a peak YoY increase of 67798.67% (in 2022) and a maximum YoY decrease of 1315949.37% (in 2022) over the last 5 years.
  • Biolife Solutions' Net Income (Quarter) stood at -$2.8 million in 2020, then plummeted by 459.92% to -$15.7 million in 2021, then skyrocketed by 677.99% to $91.0 million in 2022, then plummeted by 129.18% to -$26.6 million in 2023, then surged by 155.04% to $14.6 million in 2024.
  • Its Net Income stands at $14.6 million for Q4 2024, versus -$1.2 million for Q3 2024 and -$15.2 million for Q2 2024.